封面
市場調查報告書
商品編碼
1186669

影像誘導治療系統市場:現狀分析及預測(2022年~2028年)

Image Guided Therapy System Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球影像誘導治療系統的市場規模在預測期間內預計將以約6%的顯著成長率擴大。影像誘導治療系統,是癌症的放射治療的措施的增加,慢性病患的負擔增加,老年人口的增加等,各種各樣的要素擴大著。

本報告提供全球影像誘導治療系統市場相關調查,提供市場概要,以及各產品類型,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場簡介

第2章 調查方法或假設

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對影像誘導治療系統市場帶來的影響

第6章 影像誘導治療系統市場收益,2020年~2028年

第7章 各產品類型的市場洞察

  • 超音波設備
  • 電腦斷層攝影(CT)掃描機
  • 核磁共振影像(MRI)
  • 內視鏡
  • 正子放出斷層攝影法(PET)
  • 其他

第8章 各用途的市場洞察

  • 腦神經外科
  • 心血管手術
  • 泌尿科
  • 整形外科
  • 其他

第9章 各終端用戶的市場洞察

  • 醫院
  • 門診病人手術中心
  • 診療所

第10章 各地區的市場洞察

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 影像誘導治療系統市場市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第12章 影像誘導治療系統的市場機會

第13章 影像誘導治療系統的市場趨勢

第14章 需求面和供給方面的分析

第15章 價值鏈分析

第16章 競爭模式

第17章 企業簡介

  • Koninklijke Philips N.V.
  • Medtronic Plc.
  • Siemens Healthineers
  • Analogic Corporation
  • GE Healthcare
  • Varian Medical Systems Inc.
  • Brainlab AG
  • Olympus Corporation
  • Stryker
  • FUJIFILM Holdings Corporation

第18章 免責聲明

簡介目錄
Product Code: UMME211481

The global image guided therapy system market is expected to grow at a significant rate of around 6% during the forecast period. Image-guided therapy interrogates the use of any form of medical imaging to plan, perform, and evaluate surgical procedures and therapeutic interventions. Techniques for image-guided therapy aid in making surgeries less invasive and more precise. The most prevalent methods are Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). These techniques are likewise upheld by ultrasound, angiography, careful route hardware, following devices, and joining programming.

Moreover, the image-guided therapy system is expanding due to a number of factors, including an increase in initiatives for cancer radiotherapy, an increase in the burden of chronic diseases, and an increase in the elderly population. According to the GLOBOCAN 2020 report from the International Agency for Research on Cancer, which estimated the incidence and mortality of 36 cancers in 185 countries worldwide, an estimated 19,292,789 new cases of cancer were diagnosed in 2020 and approximately 9,958,133 people died from cancer worldwide.

Koninklijke Philips N.V., Medtronic Plc., Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems Inc., Brainlab AG, Olympus Corporation, Stryker, FUJIFILM Holdings Corporation Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst application, cardiac surgery category to witness robust CAGR during the forecast period"

Based on application, the market is segmented into neurosurgery, cardiac surgery, urology, orthopedic surgery, and others. Amongst, the cardiac surgery category is to witness higher CAGR during the forecast period owing to the growing number of chronic diseases such as cardiovascular diseases, cancer, and the rising geriatric populatioN.

Also, during the forecast period, the neurosurgery sector is likely to expand at a profitable rate. This market is primarily driven by the high prevalence of neurological disorders and the rising number of accident and trauma cases.

"Amongst end-user, the hospitals to hold a significant share in the market in 2020"

On the basis of end-user, the market is categorized into hospitals, ambulatory surgery centers, and clinics. Among these, the hospitals to hold a significant share of the market in 2020. This is mainly due to the availability of neurovascular devices, skilled healthcare professionals, and the safety & efficacy during the treatment procedures. Moreover, the growing patient pool suffering from neurovascular diseases such as brain aneurysms, and arteriovenous malformations are also contributing to the growth of this market during the forecast period. For instance, according to the Brain Aneurysms Foundation, about 30,000 people in the United States suffer a brain aneurysm rupture each year.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the IMAGE GUIDED THERAPY SYSTEM industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. Due to its well-established healthcare infrastructure, rapid adoption of advanced radiation therapies, and technological advancements. Additionally, the high demand for minimally invasive procedures and value-based reimbursements in this region will boost the growth of the image guided therapy system market due to the region's aging population and rising chronic disease cases. The well-established healthcare sector and the rising incidence of cancer are the primary drivers of the market's expansion in the United States.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The Global image guided therapy system market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the IMAGE GUIDED THERAPY SYSTEM MARKET
  • 2.2. Research Methodology of the IMAGE GUIDED THERAPY SYSTEM MARKET
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE IMAGE GUIDED THERAPY SYSTEM MARKET

6 IMAGE GUIDED THERAPY SYSTEM MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Ultrasound Systems
  • 7.2. Computed Tomography (CT) Scanners
  • 7.3. Magnetic Resonance Imaging (MRI)
  • 7.4. Endoscopes
  • 7.5. Positron Emission Tomography (PET)
  • 7.6. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Neurosurgery
  • 8.2. Cardiac Surgery
  • 8.3. Urology
  • 8.4. Orthopedic Surgery
  • 8.5. Others

9 MARKET INSIGHTS BY END-USER

  • 9.1. Hospitals
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 IMAGE GUIDED THERAPY SYSTEM MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 IMAGE GUIDED THERAPY SYSTEM MARKET OPPORTUNITIES

13 IMAGE GUIDED THERAPY SYSTEM MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. Koninklijke Philips N.V.
  • 17.2. Medtronic Plc.
  • 17.3. Siemens Healthineers
  • 17.4. Analogic Corporation
  • 17.5. GE Healthcare
  • 17.6. Varian Medical Systems Inc.
  • 17.7. Brainlab AG
  • 17.8. Olympus Corporation
  • 17.9. Stryker
  • 17.10. FUJIFILM Holdings Corporation

18 DISCLAIMER